The classification is clear; permission is a separate question
China’s 2025 medicinal psychotropic-drug catalogue lists tramadol in Class II, including compound preparations containing tramadol. The published catalogue establishes controlled status; it does not, on its own, provide a complete traveller import procedure. A product mixed with another active ingredient is not automatically outside that classification. Check every ingredient against the current rules rather than relying on the brand name or its legal status in the departure country.
Do not borrow the wrong personal-carry rule
Article 44 of the Narcotic and Psychotropic Drugs Regulation has a patient-carry paragraph specifically referring to narcotics and Class I psychotropics. Do not transfer its prescription-quantity wording to Class II tramadol as a universal allowance. Professional medical staff carrying stock is also a different scenario. We have not verified a single permit route or fixed day-supply rule that resolves every traveller’s tramadol entry. This uncertainty should be resolved with the competent authority for the actual journey, not filled with an invented limit.
Build the question around one exact product
Prepare label photographs, generic and brand names, all ingredients, strength per unit, formulation, pack size and intended total units. Explain the prescribed personal use and trip duration, with a prescription and relevant clinician letter available. Ask whether the product and amount may be carried, which evidence is required, whether any prior authorisation applies and how to declare it. Request a reply referring to the supplied details; a response about an unnamed pain medicine leaves the central question unanswered.
A connection can introduce another authority
List departure, transit and China entry points and distinguish staying airside from entering a transit country. A missed connection or baggage-reclaim requirement may change that assumption. Ask each relevant authority about its own jurisdiction and obtain operating-airline packing guidance separately. Keep documents with the medicine in identifiable packaging. Do not split or relabel a supply to avoid scrutiny; a clear account of the complete quantity is more useful than several inconsistent descriptions.
If the answer is incomplete, revise the plan before travel
Send the unanswered point back to Customs or the relevant drug-control authority, attaching the original question and reply. Ask the treating clinician how continuity can be managed if carriage is not confirmed; this page does not recommend stopping treatment, changing dose or choosing another medicine. A receiving hospital’s willingness to review a patient does not guarantee supply of the same product. Keep medication feasibility separate from airline fitness and the ground-transfer booking.
What to send ChinaMedTransfer
Send the exact product description, planned quantity, travel dates, entry and connection route, who carries it and the authority responses already obtained. Say whether you need help arranging receiving-side communication or a medication handover during ground transfer. We can organise those interfaces and a clear question set. We cannot approve controlled-drug entry or certify that a prescription alone is sufficient. Do not send identifiable medical records in the first general enquiry.